Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media (original) (raw)

• Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669–672.
  Article CAS PubMed Google Scholar
• Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296: 2410–2413.
  Article CAS PubMed Google Scholar
• Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004; 364: 2181–2187.
  Article CAS PubMed Google Scholar
• Sadelain M, Riviere I, Brentjens R . Targeting tumours with genetically enhanced T lymphocytes. Nat Rev Cancer 2003; 3: 35–45.
  Article CAS PubMed Google Scholar
• Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126–129.
  Article CAS PubMed Central PubMed Google Scholar
• Mann R, Mulligan RC, Baltimore D . Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153–159.
  Article CAS PubMed Google Scholar
• Miller AD, Buttimore C . Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895–2902.
  Article CAS PubMed Central PubMed Google Scholar
• Markowitz D, Goff S, Bank A . A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120–1124.
  CAS PubMed Central PubMed Google Scholar
• Markowitz D, Goff S, Bank A . Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167: 400–406.
  Article CAS PubMed Google Scholar
• Danos O, Mulligan RC . Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460–6464.
  Article CAS PubMed PubMed Central Google Scholar
• Rigg RJ, Chen J, Dando JS, Forestell SP, Plavec I, Bohnlein E . A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Virology 1996; 218: 290–295.
  Article CAS PubMed Google Scholar
• Otto E, Jones-Trower A, Vanin EF, Stambaugh K, Mueller SN, Anderson WF et al. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther 1994; 5: 567–575.
  Article CAS PubMed Google Scholar
• Chong H, Vile RG . Replication-competent retrovirus produced by a ‘split-function’ third generation amphotropic packaging cell line. Gene Therapy 1996; 3: 624–629.
  CAS PubMed Google Scholar
• Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK . High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430–7436.
  CAS PubMed Central PubMed Google Scholar
• Forestell SP, Dando JS, Chen J, de Vries P, Bohnlein E, Rigg RJ . Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer. Gene Therapy 1997; 4: 600–610.
  Article CAS PubMed Google Scholar
• Sheridan PL, Bodner M, Lynn A, Phuong TK, DePolo NJ, de la Vega Jr DJ et al. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer. Mol Ther 2000; 2: 262–275.
  Article CAS PubMed Google Scholar
• Zhao Y, Low W, Collins MK . Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors. Gene Therapy 2000; 7: 300–305.
  Article CAS PubMed Google Scholar
• Yu SS, Kim JM, Kim S . High efficiency retroviral vectors that contain no viral coding sequences. Gene Therapy 2000; 7: 797–804.
  Article CAS PubMed Google Scholar
• Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM . Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002; 13: 1605–1610.
  Article CAS PubMed Google Scholar
• Gerin PA, Gilligan MG, Searle PF, Al-Rubeai M . Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium. Hum Gene Ther 1999; 10: 1965–1974.
  Article CAS PubMed Google Scholar
• Gerin PA, Searle PF, Al-Rubeai M . Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18. Biotechnol Prog 1999; 15: 941–948.
  Article CAS PubMed Google Scholar
• Glimm H, Flugge K, Mobest D, Hofmann VM, Postmus J, Henschler R et al. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium. Hum Gene Ther 1998; 9: 771–778.
  Article CAS PubMed Google Scholar
• McTaggart S, Al-Rubeai M . Effects of culture parameters on the production of retroviral vectors by a human packaging cell line. Biotechnol Prog 2000; 16: 859–865.
  Article CAS PubMed Google Scholar
• Chan LM, Coutelle C, Themis M . A novel human suspension culture packaging cell line for production of high-titre retroviral vectors. Gene Therapy 2001; 8: 697–703.
  Article CAS PubMed Google Scholar
• Schilz AJ, Kuhlcke K, Fauser AA, Eckert HG . Optimization of retroviral vector generation for clinical application. J Gene Med 2001; 3: 427–436.
  Article CAS PubMed Google Scholar
• Budak-Alpdogan T, Przybylowski M, Gonen M, Sadelain M, Bertino J, Riviere I . Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol. Hum Gene Ther 2006; 17: 780–794.
  Article CAS PubMed Google Scholar
• Kotani H, Newton PBR, Zhang S, Chiang YL, Otto E, Weaver L et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994; 5: 19–28.
  Article CAS PubMed Google Scholar
• Pan D, Whitley CB . Closed hollow-fiber bioreactor: a new approach to retroviral vector production. J Gene Med 1999; 1: 433–440.
  Article CAS PubMed Google Scholar
• Merten OW . State-of-the-art of the production of retroviral vectors. J Gene Med 2004; 6 (Suppl 1): S105–S124.
  Article CAS PubMed Google Scholar
• Przybylowski M, Hakakha A, Stefanski J, Hodges J, Sadelain M, Riviere I . Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in cell factories. Gene Therapy 2006; 13: 95–100.
  Article CAS PubMed Google Scholar
• Merten OW, Cruz PE, Rochette C, Geny-Fiamma C, Bouquet C, Goncalves D et al. Comparison of different bioreactor systems for the production of high titer retroviral vectors. Biotechnol Prog 2001; 17: 326–335.
  Article CAS PubMed Google Scholar
• Ghani K, Garnier A, Coelho H, Transfiguracion J, Trudel P, Kamen A . Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Biotechnol Bioeng 2006; 95: 653–660.
  Article CAS PubMed Google Scholar
• Pizzato M, Merten OW, Blair ED, Takeuchi Y . Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. Gene Therapy 2001; 8: 737–745.
  Article CAS PubMed Google Scholar
• Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV . Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 1991; 65: 2220–2224.
  CAS PubMed Central PubMed Google Scholar
• Young WB, Link Jr CJ . Chimeric retroviral helper virus and picornavirus IRES sequence to eliminate DNA methylation for improved retroviral packaging cells. J Virol 2000; 74: 5242–5249.
  Article CAS PubMed Central PubMed Google Scholar
• Reeves L, Smucker P, Cornetta K . Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience. Hum Gene Ther 2000; 11: 2093–2103.
  Article CAS PubMed Google Scholar
• Kelly PF, Vandergriff J, Nathwani A, Nienhuis AW, Vanin EF . Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood 2000; 96: 1206–1214.
  CAS PubMed Google Scholar
• Relander T, Brun AC, Olsson K, Pedersen L, Richter J . Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34(+) cells increases gene transfer mediated by GALV pseudotyped vectors. Mol Ther 2002; 6: 400–406.
  Article CAS PubMed Google Scholar
• Relander T, Johansson M, Olsson K, Ikeda Y, Takeuchi Y, Collins M et al. Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol Ther 2005; 11: 452–459.
  Article CAS PubMed Google Scholar
• Cote J, Garnier A, Massie B, Kamen A . Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol Bioeng 1998; 59: 567–575.
  Article CAS PubMed Google Scholar
• Qiao J, Roy V, Girard M-H, Caruso M . High translation efficiency is mediated by the encephalomyocarditis virus IRES if the natural sequence surrounding the 11th AUG is retained. Hum Gene Ther 2002; 13: 881–887.
  Article CAS PubMed Google Scholar